secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cann American Corp. (—)
CIK:        0001368620
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0001683168-23-001536
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cann American completes acquisition of Prodigy Stem Cell; appoints founder as director
--------------------------------------------------------------------------------

- Entered binding LOI on Jan 30, 2023 to acquire Prodigy Stem Cell, LLC as wholly owned subsidiary.
- Acquisition completed on March 1, 2023; Prodigy becomes wholly owned subsidiary.
- Prodigy Stem Cell focuses on sales, marketing, and consulting for regenerative medicines.
- Peter Caruso, founder of Prodigy, appointed as director effective March 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/0001683168-23-001536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368620/000168316823001536/cann_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-001536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer